1 |
Guo, Y. and N. Kyprianou. 1999. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1- mediated apoptosis. Cancer Res. 59: 1366-1371
PUBMED
ScienceOn
|
2 |
Ji, L., G. Zhang, and Y. Hirabayashi. 1995. Inhibition of tumor necrosis factor alpha- and ceramide-induced internucleosomal DNA fragmentation by herbimycin A in U937 cells. Biochem. Biophys. Res. Commun. 212: 640-647
DOI
PUBMED
ScienceOn
|
3 |
Lakka, S. S., C. S. Gondi, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, and J. S. Rao. 2004. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689
DOI
ScienceOn
|
4 |
Meier, P. and G. Evan. 1998. Dying like flies. Cell 95: 295- 298
DOI
ScienceOn
|
5 |
Nakazawa, M., T. Uehara, and Y. Nomura. 1997. Koningic acid (a potent glyceraldehyde-3-phosphate dehydrogenase inhibitor)- induced fragmentation and condensation of DNA in NG108-15 cells. J. Neurochem. 68: 2493-2499
DOI
PUBMED
ScienceOn
|
6 |
Pieper, A. A., A. Verma, J. Zhang, and S. H. Snyder. 1999. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20: 171-181
DOI
ScienceOn
|
7 |
Itoh, Y., K. Kodama, K. Furuya, S. Takahashi, T. Haneishi, Y. Takiguchi, and M. Arai. 1980. A new sesquiterpene antibiotic, heptelidic acid: Producing organisms, fermentation, isolation and characterization. J. Antibiot. (Tokyo) 33: 468-473
DOI
|
8 |
Budihardjo, I., H. Oliver, M. Lutter, X. Luo, and X. Wang. 1999. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15: 269-290
DOI
ScienceOn
|
9 |
Ching, J. C., N. L. Jones, P. J. Ceponis, M. A. Karmali, and P. M. Sherman. 2002. Escherichia coli Shiga-like toxins induce apoptosis and cleavage of poly (ADP-ribose) polymerase via in vitro activation of caspases. Infect. Immun. 70: 4669-4677
DOI
ScienceOn
|
10 |
Maulik, N. and D. K. Das. 2002. Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 33: 1047-1060
DOI
ScienceOn
|
11 |
Yadavilli, S. and P. M. Muganda. 2004. Diepoxybutane induces caspase and p53-mediated apoptosis in human lymphoblasts. Toxicol. Appl. Pharmacol. 195: 154-165
DOI
ScienceOn
|
12 |
Tanaka, Y., K. Shiomi, K. Kamei, M. Sugoh-Hagino, Y. Enomoto, F. Fang, et al. 1998. Antimalarial activity of radicicol, heptelidic acid and other fungal etabolites. J. Antibiot. (Tokyo) 51: 153- 160
DOI
ScienceOn
|
13 |
Dove, A. 2001. Making a living out of the art of dying. Nat. Biotechnol. 19: 615-619
DOI
PUBMED
ScienceOn
|
14 |
Zychlinsky, A. 1993. Programmed cell death in infectious diseases. Trends Microbiol. 1: 114-117
DOI
PUBMED
ScienceOn
|
15 |
Miura, M., H. Zhu, R. Rotello, E. A. Hartwieg, and J. Yuan. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660
DOI
PUBMED
ScienceOn
|
16 |
Agrawal, S., M. L. Agarwal, M. Chatterjee-Kishore, G. R. Stark, and G. M. Chisolm. 2002. Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Mol. Cell Biol. 22: 1981-1992
DOI
ScienceOn
|
17 |
Zimmermann, K. C., C. Bonzon, and D. R. Green. 2001. The machinery of programmed cell death. Pharmacol. Ther. 92: 57- 70
DOI
ScienceOn
|
18 |
Kakeya, H., H. P. Zhang, K. Kobinata, R. Onose, C. Onozawa, T. Kudo, and H. Osada. 1997. Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cells. J. Antibiot. (Tokyo) 50: 370-372
DOI
ScienceOn
|
19 |
Ujibe, M., S. Kanno, Y. Osanai, K. Koiwai, T. Ohtake, K. Kimura, K. Uwai, M. Takeshita, and M. Ishikawa. 2005. Octylcaffeate induced apoptosis in human leukemia U937 cells. Biol. Pharm. Bull. 28: 2338-2341
DOI
ScienceOn
|
20 |
Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, et al. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12: 806-819
DOI
ScienceOn
|
21 |
Goodwin, C. J., S. J. Holt, S. Downes, and N. J. Marshall. 1995. Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS. J. Immunol. Methods 179: 95-103
DOI
ScienceOn
|
22 |
Webster, K. A. 2003. Therapeutic angiogenesis: A complex problem requiring a sophisticated approach. Cardiovasc. Toxicol. 3: 283-298
DOI
PUBMED
ScienceOn
|
23 |
Endo, A., K. Hasumi, K. Sakai, and T. Kanbe. 1985. Specific inhibition of glyceraldehyde-3-phosphate dehydrogenase by koningic acid (heptelidic acid). J. Antibiot. (Tokyo) 38: 920-925
DOI
|
24 |
Hanahan, D. and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
DOI
ScienceOn
|